India Drafts Guidelines To Require CRO Registration Of Trials
This article was originally published in PharmAsia News
India is considering a requirement that clinical research companies in the country register both themselves and the trials they run. The nation's health ministry has drafted guidelines for registration, intended in part to prevent unethical experiments on humans. Drug Controller General of India Surinder Singh said the draft, being reviewed by an internal committee, was drawn up in part with the World Health Organization and volunteering companies. The next step is for the guidelines to be presented to the Drugs Technical Advisory Board for approval, with the new rules expected to be in place before the new year. (Click here for more
You may also be interested in...
A WHO recommendation to explicitly exempt low-THC CBD from international narcotics controls has been emphatically rejected by UN member states. The CBD industry had hoped for a positive outcome to remove regulatory pressure on product manufacturers in Europe and around the world.
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer/BioNTech's COVID-19 vaccine in 2021 and beyond.
How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.